Original Research ArticleInternational Journal of Community Medicine and Public Health
Publication: Efficacy, tolerability and compliance of nicotine patches among Qatari population: a retrospective study
Int J Community Med Public Health. 2026;13(7):3333-3337.DOI10.18203/2394-6040.ijcmph20262221
Abstract
Background Tobacco use is a primary global health concern with significant adverse effects on public health and life expectancy. This study evaluated the safety, efficacy, and compliance of nicotine replacement therapy (NRT) among smokers in the Qatar population.
Methods A retrospective analysis was conducted on 400 individuals enrolled in a smoking cessation program in an outpatient department. The participants were randomized into a NRT group (300 participants) and a control group (100 participants).
Results No significant differences were found in adverse effects between the NRT and control groups, including palpitations, chest pains, nausea, vomiting, gastrointestinal complaints, and insomnia. Skin allergy or itching was rare in the NRT group. There was no statistically significant increase in anxiety or depressive symptoms associated with NRT use. Additionally, there was no significant difference in both groups' primary outcomes or efficacy.
Conclusion These findings suggest that NRT is a safe and effective smoking cessation method for smokers in the Qatar population. The use of NRT should be considered alongside counseling and medical monitoring to improve smoking cessation rates.
Keywords
Affiliations
- Department of Medicine, Hamad Medical Corporation, Doha, Qatar; Clinical Medicine, Weill Cornell Medicine, Doha, Qatar; College of Medicine, Qatar University, Doha, Qatar
- Ambulatory Care Medicine, Hamad Medical Corporation, Doha, Qatar
- Medical Education Department, Hamad Medical Corporation, Doha, Qatar
- Department of Medicine, Hamad Medical Corporation, Doha, Qatar; Clinical Medicine, Weill Cornell Medicine, Doha, Qatar
- Department of Medicine, Hamad Medical Corporation, Doha, Qatar
- Nursing Department, Hamad Medical Corporation, Doha, Qatar
- Tobacco Control Center, Hamad Medical Corporation, Doha, Qatar
